NCT01646554View on ClinicalTrials.gov

Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases

PHASE2/PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2016

Conditions
Colorectal Cancer MetastaticLiver MetastasesKRAS Mutated Colorectal Cancer
Interventions
DRUG

Modified FOLFOX6

BIOLOGICAL

Aflibercept

Targeted therapy

PROCEDURE

Surgery

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK